C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/00 (2006.01) C12Q 1/37 (2006.01)
Patent
CA 2393767
A method for identifying molecules and designing novel pharmaceuticals is disclosed. The disclosed method of novel pharmaceutical design identifies a novel chemical group that triggers a mechanism of action for an identified reaction, thereby avoiding the various structural complexities associated with the application of the structure-based drug design. Additionally, examples of potential therapeutics identified by the mechanism based drug design method are provided.
L'invention concerne un procédé relatif à l'identification et à la conception de nouveaux produits pharmaceutiques. On identifie un nouveau groupe chimique déclenchant un mécanisme d'action correspondant à une réaction identifiée, ce qui permet d'éviter les diverses complexités structurelles associées à la conception de médicament reposant sur un schéma structurel. L'invention concerne en outre des exemples thérapeutiques potentiels révélés par le biais du procédé considéré.
Arad Dorit
Bollon Arthur P.
Peek Andrew S.
Poland Bradley W.
Young David C.
Arad Dorit
Bollon Arthur P.
Exegenics Inc.
Kirby Eades Gale Baker
Peek Andrew S.
LandOfFree
Molecules derived from mechanism based drug design does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Molecules derived from mechanism based drug design, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Molecules derived from mechanism based drug design will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1455378